Details for New Drug Application (NDA): 018150
✉ Email this page to a colleague
NDA 018150 describes THALLOUS CHLORIDE TL 201, which is a drug marketed by Bracco, Curium, Ge Healthcare, Lantheus Medcl, and Trace Life, and is included in six NDAs. It is available from one supplier. Additional details are available on the THALLOUS CHLORIDE TL 201 profile page.
The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.
The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.
Summary for 018150
| Tradename: | THALLOUS CHLORIDE TL 201 |
| Applicant: | Curium |
| Ingredient: | thallous chloride tl-201 |
| Patents: | 0 |
Pharmacology for NDA: 018150
| Mechanism of Action | Radiopharmaceutical Activity |
Suppliers and Packaging for NDA: 018150
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| THALLOUS CHLORIDE TL 201 | thallous chloride tl-201 | INJECTABLE;INJECTION | 018150 | NDA | Curium US LLC | 69945-120 | 69945-120-28 | 1 VIAL in 1 CAN (69945-120-28) / 2.8 mL in 1 VIAL |
| THALLOUS CHLORIDE TL 201 | thallous chloride tl-201 | INJECTABLE;INJECTION | 018150 | NDA | Curium US LLC | 69945-120 | 69945-120-56 | 1 VIAL in 1 CAN (69945-120-56) / 5.6 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1mCi/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
